Profile
DHR-PB TMO DHR IDXX A IQV
Company Name Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc. IQVIA Holdings Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $916.76B $184.93B $151.04B $51.27B $33.86B $31.52B
Employees 79.00K 125.00K 61.00K 11.00K 17.90K 89.00K
CEO Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell Ari Bousbib
Ratings
DHR-PB TMO DHR IDXX A IQV
Quant Rating Score 5 3 3 3 4 3
Quant Rating Strong Buy Neutral Neutral Neutral Buy Neutral
Trading
DHR-PB TMO DHR IDXX A IQV
Last Close $1261.26 $489.74 $205.29 $647.03 $124.96 $188.73
High 52 $1261.26 $624.21 $278.02 $682.78 $152.6 $251.55
Low 52 $1261.26 $390.2 $174.64 $361.04 $99.29 $137
Price vs. 52 Week High 0 % -21.54 % -26.16 % -5.24 % -18.11 % -24.97 %
Price vs. 52 Week Low 0 % 25.51 % 17.55 % 79.21 % 25.85 % 37.76 %
Total Return
DHR-PB TMO DHR IDXX A IQV
1 Month Return 0 % 1.56 % -0.75 % 12.91 % 4.27 % -2.99 %
3 Month Return 0 % 21.3 % 7.78 % 25.5 % 10.31 % 33.83 %
6 Month Return 0 % -7.41 % -1.19 % 48.02 % -2.31 % -0.04 %
9 Month Return 0 % -7.53 % -14.35 % 53.42 % -9.43 % -6.03 %
YTD Return 0 % -5.86 % -10.57 % 56.5 % -6.98 % -3.96 %
1 Year Return 0 % -19.94 % -23.12 % 32.78 % -12.33 % -24.75 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DHR-PB TMO DHR IDXX A IQV
Dividend Yield Percentage (TTM) 0.58 % 0.33 % 0.56 % - 0.82 % -
Dividend Paid and Capex Coverage Ration (TTM) 2.91 % 3.76 % 2.91 % 6.89 % 2.36 % 4.31 %
Dividend Per Share (TTM) 1.18 % 1.64 % 1.18 % - 0.98 % -
Payout Ratio (TTM) 23.85 % 9.26 % 23.85 % - 23.76 % -
Growth
DHR-PB TMO DHR IDXX A IQV
Asset Growth -8.22 % -1.42 % -8.22 % 1.03 % 10.06 % 0.82 %
Gross Profit Growth 1.23 % 3.44 % 1.23 % 8.63 % 2.02 % 2.6 %
Revenue Growth -0.06 % 0.05 % -0.06 % 6.46 % -4.73 % 2.81 %
Revenue 3 Year -20.76 % 12.79 % -20.76 % 25.23 % -1.99 % 17.22 %
Revenue 5 Year 30.38 % 75.79 % 30.38 % 69.09 % 29.92 % 49.51 %
Revenue 10 Year 15.17 % 164.64 % 15.17 % 218.38 % 85.12 % 99.19 %
EBIT Growth -7.62 % 13.28 % -7.62 % 3.47 % 12.76 % 11.68 %
Net Income Growth -18.16 % 5.67 % -18.16 % 5.07 % 3.95 % 1.1 %
Net Income 3 Yeari Growth Per Share -40.75 % -15.42 % -40.75 % 23.15 % 5.98 % 50.05 %
Net Income 5 Yeari Growth Per Share 26.78 % 79.48 % 26.78 % 116.76 % 91.02 % 673.56 %
Net Income 10 Yeari Growth Per Share 44.14 % 248.59 % 44.14 % 492.42 % 269.11 % 171.99 %
Operating Income Growth -6.52 % 6.97 % -6.52 % 2.84 % 10.22 % 11.38 %
Operating Cash Flow Growth (CFG) -6.64 % 3.1 % -6.64 % 2.48 % -1.19 % 26.38 %
Operating 3 Year CFG -21.78 % -6.33 % -21.78 % 27.03 % 37.6 % -2.54 %
Operating 5 Year CFG 65.54 % 82.49 % 65.54 % 111.28 % 102.58 % 106.26 %
Operating 10 Year CFG 70.94 % 244.88 % 70.94 % 378.1 % 309.5 % 344.1 %
EPS Growth -17.24 % 6.76 % -17.24 % 5.9 % 5.21 % 2.44 %
EPS Diluted Growth -17.08 % 6.99 % -17.08 % 6.06 % 5.73 % 2.74 %
Book Value Per Share -6.67 % 7.15 % -6.67 % 8.24 % 2.3 % 0.63 %
Share Holder 3 Year Equity Growth Per Share 7.23 % 25.29 % 7.23 % 138.87 % 14.63 % 6.01 %
Share Holder 5 Year Equity Growth Per Share 60.08 % 74.85 % 60.08 % 838.67 % 28.96 % 8.76 %
Share Holder 10 Year Equity Growth Per Share 103.57 % 151.37 % 103.57 % 1547.69 % 63 % 708.4 %
Dividend Per Share Growth -5.75 % 12.64 % -5.75 % - 4.82 % -
Dividend 3 Year Growth Per Share 1.18 % 52.23 % 1.18 % - 13 % -
Dividend 5 Year Growth Per Share 42.62 % 105.55 % 42.62 % - 31.51 % -
Dividend 10 Year Growth Per Share 224 % 158.83 % 224 % - 136.56 % -
Debt Growth -18.07 % -10.43 % -18.07 % -7.53 % 23.28 % 1.78 %
Free Cash Flow Growth -8.39 % 4.91 % -8.39 % 3.26 % -6.85 % 40.93 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024 31 Dec 2024
Profitability
DHR-PB TMO DHR IDXX A IQV
Gross Profit Margin TTM 61.52 % 39.58 % 61.52 % 61.54 % 53.35 % 34.25 %
Return on Assets TTM 4.18 % 6.5 % 4.18 % 29.59 % 9.59 % 4.32 %
Return on Equity TTM 6.69 % 13.27 % 6.69 % 64.42 % 19.46 % 19.96 %
Return on Capital Employed TTM 6.93 % 8.97 % 6.93 % 59.57 % 13.97 % 10.34 %
Net Income Per EBT TTM 83.73 % 93.8 % 83.73 % 80.28 % 85.05 % 80.8 %
EBT Per Ebit TTM 78.61 % 88.39 % 78.61 % 97.81 % 96.75 % 70.29 %
EBIT Per Revenue TTM 21.59 % 18.38 % 21.59 % 31.09 % 21.38 % 13.87 %
Cash Flow To Debt Ratio TTM 33.25 % 21.51 % 33.25 % 73.21 % 45.35 % 16.67 %
Receivables Turnover TTM 5.32 4.31 5.32 6.09 4.85 4.61
Payables Turnover TTM 5.36 8.76 5.36 13.32 5.98 3.04
Inventory Turnover TTM 3.44 4.7 3.44 3.96 3.12 -
Fixed Asset Turnover TTM 374.68 % 448.49 % 374.68 % 464.4 % 346.65 % 1924.02 %
Asset Turnover TTM 29.42 % 42.69 % 29.42 % 121.22 % 54.52 % 54.83 %
Operating Cash Flow Per Share TTM 8.61 20.05 8.61 11.26 5.56 15.23
Free Cash Flow Per Share TTM 6.79 16.32 6.79 9.63 4.17 11.7
Cash Per Share TTM 412.7 % 1690.48 % 412.7 % 204.69 % 521.4 % 1273.57 %
Operating Cash Flow Sales Ratio TTM 25.69 % 17.54 % 25.69 % 22.43 % 23.91 % 16.67 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.81 % 81.42 % 78.81 % 85.49 % 75.02 % 76.81 %
Cash Flow Coverage Ratios TTM 33.25 % 21.51 % 33.25 % 73.21 % 45.35 % 16.67 %
Price To Free Cash Flows Ratio TTM 30.19 29.97 31.06 66.21 28.48 15.68
Price To Operating Cash Flows Ratio TTM 23.81 24.43 24.5 56.89 21.43 12.17
Price Cash Flow Ratio TTM 23.81 24.43 24.5 56.89 21.43 12.17
Income Statement (TTM)
DHR-PB TMO DHR IDXX A IQV
Revenue $23.88B $42.88B $23.88B $3.9B $6.51B $15.41B
Gross Profit $14.21B $17.73B $14.21B $2.38B $3.54B $5.38B
Gross Profit Ratio 59.5% 41.34% 59.5% 61.04% 54.3% 34.89%
EBITDA $7.28B $11.8B $7.28B $1.28B $1.87B $3.49B
Net Income $3.9B $6.34B $3.9B $0.89B $1.29B $1.37B
EPS Diluted 5.29 16.53 5.29 10.67 4.43 7.49
Balance Sheet (MRQ)
DHR-PB TMO DHR IDXX A IQV
Long Term Debt $16.47B $30.3B $16.47B $0.55B $3.49B $13.01B
Total Liabilities $27.99B $47.65B $27.99B $1.7B $5.95B $20.83B
Total Equity $49.55B $49.67B $49.55B $1.6B $5.9B $6.07B
Total Investments $1.82B $2.12B $1.82B $0.06B $0.18B $0.52B
Total Debt $17.15B $32.78B $17.15B $0.99B $3.57B $14.16B
Total Assets $77.54B $97.32B $77.54B $3.29B $11.85B $26.9B
Cash Flow Statement (TTM)
DHR-PB TMO DHR IDXX A IQV
Net Income $3.9B $6.34B $3.9B $0.89B $1.29B $1.37B
Inventory $0.15B $-0.03B $0.15B $-0.03B $0.03B $0B
Dividends Paid $-0.77B $-0.58B $-0.77B $0B $-0.27B $0B
Operating Cash Flow $6.69B $8.67B $6.69B $0.93B $1.75B $2.72B
Capital Expenditure $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B $-0.6B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 125.74
ACRS Aclaris Therapeutics, Inc. 1.925
ADVB Advanced Biomed Inc. Common Stock 0.4432
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 3.22
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.4294
BIAF bioAffinity Technologies, Inc. 0.2472
BIAFW bioAffinity Technologies, Inc. 0.07
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.77
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 8.69
CDNA CareDx, Inc 13.66
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.7605
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 163.35
CSTL Castle Biosciences, Inc. 24.03
Unlock